VRNA Stock Ownership Breakdown

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own VRNA shares is 196, representing 88.94% of the company's common stock.

ADVISOR GROUP HOLDINGS, INC., in the last quarter, reduced its stake in VRNA by -18.44% restricting it's holding to 2.56 thousand shares of worth nearly $41.12K. QUANTBOT TECHNOLOGIES LP also lessened -80.03% of the VRNA shares from its portfolio, reducing its holding to 2.46 thousand shares of worth $39.55K. UBS GROUP AG also shunned VRNA shares holding by -8.89% last quarter which brought its holding to 1.84 thousand shares worth $29.53K.

As per its latest 13F filing, CITADEL ADVISORS LLC increased its stake in VRNA by 404.48% in the last quarter. The institutional holder raised its holding to 142.21 thousand shares having worth more than $2.29M. WELLINGTON MANAGEMENT GROUP LLP also added 3.32% more shares of VRNA to its portfolio, raising its holding to 3.91 million shares of worth $62.90M. EVENTIDE ASSET MANAGEMENT, LLC also increased its VRNA shares holding by 58.77% which brought its holding to 2.19 million shares worth $35.20M.

The insider with the most stakes in VRNA is Blavatnik Len , at the company. Additionally, VRNA stock is highly held by 10 percent owner Access Industries Holdings LLC and President and CEO ZACCARDELLI DAVID among others.

Company executives, directors, and other insiders own 1.85% percent of Verona Pharma plc's stock. Within the last six months, there have been 39 transaction(s) in which VRNA insiders have sold stock, totaling 5.06M shares. Insiders that have sold shares include HAHN MARK W, ZACCARDELLI DAVID, and RICKARD KATHLEEN A..

There have been 4 transaction(s) during the past 6-months in which Verona Pharma plc insiders have bought stock, totalling 137240 shares

Around 560.08M Verona Pharma plc shares are held by insiders, which represents about 1.85% of VRNA stock.

VRNA , Blavatnik Len holds the largest portfolio of the company's shares. VRNA shares owned by Blavatnik total nearly 55.91 million.

CITADEL ADVISORS LLC is the largest institutional owner in VRNA which holds 142.21 thousand shares worth $2.29M or 0.18% of the total VRNA shares outstanding followed by ADVISOR GROUP HOLDINGS, INC. with ownership of 2.56 thousand shares representing 0% of the VRNA ownership. QUANTBOT TECHNOLOGIES LP is the third largest stakeholder with 2.46 thousand shares or 0% of the ownership worth more than $39.55K.

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the VRNA is concerned, it is a stock which is optionable.

Number of VRNA shares short is 6.90M. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

As of today, 81.83M shares of VRNA are outstanding.

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, VRNA has 392.17M shares in float.

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for VRNA is 8.18.